LIFECORE BIOMEDICAL, INC. Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal
LIFECORE BIOMEDICAL, INC. (LFCR) reported Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal of $0 for the 12-month period ending 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal · last filed 2024-03-20
- LIFECORE BIOMEDICAL, INC. disposal group, not discontinued operation, gain (loss) on disposal for the quarter ending 2022-05-29 was -$101.00K.
- LIFECORE BIOMEDICAL, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2023 was $0.00.
- LIFECORE BIOMEDICAL, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2022 was -$336.00K.
- LIFECORE BIOMEDICAL, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2021 was $0.00.
- LIFECORE BIOMEDICAL, INC. disposal group, not discontinued operation, gain (loss) on disposal for fiscal 2020 was $0.00.
| Period end | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 0 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 3 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 9 month | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal 12 month |
|---|---|---|---|---|
| 2023-05-28 | $0.00 10-K · filed 2024-03-20 | |||
| 2022-05-29 | -$101.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | -$336.00K 10-K · filed 2024-03-20 | ||
| 2022-02-27 | -$235.00K 10-K · filed 2024-03-20 | |||
| 2021-05-30 | $0.00 10-K · filed 2024-03-20 | |||
| 2020-05-31 | $0.00 10-K/A · filed 2023-03-16 | |||
| 2012-06-24 | $100.00K 10-Q · filed 2013-01-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |